sglt2 or glp 1 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain Use of GLP-1 Receptor Agonists

The conjectural stimulation of the GHRH receptor by Tesamorelin and the cAMP-PKA signaling pathway might promote the secretion and distribution of growth hormone (hGH) from somatotroph cells in the pituitary gland

Two of these case series suggest that dosage may be of importance, with individual differences and higher doses more effective than lower ones where dose was titrated up (dosage ranges 6001800 mg per day)

Loss of the Tumor Suppressor LKB1 Promotes Metabolic Reprogramming of Cancer Cells via HIF-1

Since both address different concerns, they can be used on alternate days

However, a question arises: Does glutathione increase uric acid levels